Gena Wang

Stock Analyst at Barclays

(2.26)
# 2,661
Out of 4,893 analysts
203
Total ratings
40.3%
Success rate
-2.67%
Average return

Stocks Rated by Gena Wang

Ionis Pharmaceuticals
Jul 1, 2025
Upgrades: Overweight
Price Target: $51$57
Current: $42.38
Upside: +34.50%
Sarepta Therapeutics
Jun 17, 2025
Maintains: Overweight
Price Target: $89$29
Current: $19.07
Upside: +52.11%
Avidity Biosciences
Jun 10, 2025
Maintains: Overweight
Price Target: $57$59
Current: $31.47
Upside: +87.48%
Solid Biosciences
May 16, 2025
Maintains: Overweight
Price Target: $15$10
Current: $5.42
Upside: +84.50%
Sangamo Therapeutics
May 14, 2025
Maintains: Overweight
Price Target: $9$5
Current: $0.50
Upside: +900.00%
Cellectis
May 13, 2025
Maintains: Overweight
Price Target: $5$4
Current: $1.65
Upside: +142.42%
CRISPR Therapeutics AG
May 9, 2025
Maintains: Equal-Weight
Price Target: $56$42
Current: $59.00
Upside: -28.81%
4D Molecular Therapeutics
May 9, 2025
Maintains: Overweight
Price Target: $45$38
Current: $4.35
Upside: +773.56%
PTC Therapeutics
May 8, 2025
Maintains: Equal-Weight
Price Target: $56$42
Current: $49.51
Upside: -15.17%
Cytokinetics
May 8, 2025
Maintains: Overweight
Price Target: $55$53
Current: $36.59
Upside: +44.85%
Maintains: Equal-Weight
Price Target: $8$11
Current: $8.88
Upside: +23.87%
Maintains: Equal-Weight
Price Target: $31$25
Current: $22.03
Upside: +13.48%
Maintains: Equal-Weight
Price Target: $45$40
Current: $34.28
Upside: +16.69%
Maintains: Overweight
Price Target: $26$31
Current: $5.93
Upside: +422.77%
Maintains: Overweight
Price Target: $55$26
Current: $12.16
Upside: +113.82%
Maintains: Equal-Weight
Price Target: $435$467
Current: $479.53
Upside: -2.61%
Maintains: Equal-Weight
Price Target: $5$3
Current: $3.06
Upside: -1.96%
Maintains: Underweight
Price Target: $3$4
Current: $4.48
Upside: -10.71%
Maintains: Overweight
Price Target: $295$329
Current: $322.58
Upside: +1.99%
Maintains: Overweight
Price Target: $110$86
Current: $58.82
Upside: +46.21%
Maintains: Overweight
Price Target: $55$50
Current: $9.06
Upside: +451.88%
Maintains: Overweight
Price Target: $83$81
Current: $31.04
Upside: +161.00%
Maintains: Overweight
Price Target: $93$94
Current: $39.71
Upside: +136.72%
Maintains: Equal-Weight
Price Target: $7$9
Current: $13.67
Upside: -34.14%
Upgrades: Equal-Weight
Price Target: $16$25
Current: $14.48
Upside: +72.65%
Maintains: Overweight
Price Target: $32$18
Current: $8.62
Upside: +108.82%
Maintains: Underweight
Price Target: $21$9
Current: $3.53
Upside: +155.32%
Initiates: Buy
Price Target: $275
Current: $5.85
Upside: +4,600.85%